Christina Wenglén

612 total citations
17 papers, 436 citations indexed

About

Christina Wenglén is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Christina Wenglén has authored 17 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Christina Wenglén's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Cell Adhesion Molecules Research (5 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Christina Wenglén is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Cell Adhesion Molecules Research (5 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Christina Wenglén collaborates with scholars based in Sweden, Germany and Norway. Christina Wenglén's co-authors include Dick Heinegård, Matthias Mörgelin, Rupert Timpl, Charlotte Wiberg, Tore Saxne, Bengt Månsson, Gunilla Westergren‐Thorsson, Anna‐Karin Larsson‐Callerfelt, Kristina Rydell‐Törmänen and Viveka Tillgren and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Christina Wenglén

17 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christina Wenglén Sweden 10 150 123 107 90 57 17 436
Martin Siczkowski United Kingdom 16 293 2.0× 112 0.9× 109 1.0× 80 0.9× 39 0.7× 23 692
He Lv China 17 396 2.6× 147 1.2× 74 0.7× 38 0.4× 19 0.3× 68 850
Jukka Vääräniemi Finland 11 452 3.0× 116 0.9× 77 0.7× 32 0.4× 32 0.6× 14 746
Larisa Ryzhova United States 14 218 1.5× 21 0.2× 137 1.3× 99 1.1× 97 1.7× 19 584
T. Kimura Japan 10 255 1.7× 246 2.0× 42 0.4× 94 1.0× 24 0.4× 20 919
Yawen Ju United States 12 205 1.4× 93 0.8× 48 0.4× 22 0.2× 34 0.6× 21 510
Serena De Vita United States 13 283 1.9× 124 1.0× 47 0.4× 13 0.1× 51 0.9× 29 621
Wilmer B Roberts United States 5 309 2.1× 22 0.2× 101 0.9× 33 0.4× 52 0.9× 5 459
Ana Kostić United States 11 199 1.3× 76 0.6× 17 0.2× 292 3.2× 32 0.6× 22 767
Elizabeth A. Hawthorne United States 9 285 1.9× 26 0.2× 347 3.2× 134 1.5× 58 1.0× 11 722

Countries citing papers authored by Christina Wenglén

Since Specialization
Citations

This map shows the geographic impact of Christina Wenglén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Wenglén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Wenglén more than expected).

Fields of papers citing papers by Christina Wenglén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Wenglén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Wenglén. The network helps show where Christina Wenglén may publish in the future.

Co-authorship network of co-authors of Christina Wenglén

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Wenglén. A scholar is included among the top collaborators of Christina Wenglén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Wenglén. Christina Wenglén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Trinh‐Minh, Thuong, Andrea‐Hermina Györfi, Xiang Zhou, et al.. (2025). Antifibrotic effects of specific targeting of the 5‐hydroxytryptamine 2B receptor (5‐HT2BR) in murine models and ex vivo models of scleroderma skin. Arthritis & Rheumatology. 77(8). 1063–1076. 2 indexed citations
2.
Dellgren, Göran, et al.. (2023). Pulmonary 5-HT2B receptor expression in fibrotic interstitial lung diseases. Acta Histochemica. 125(3). 152024–152024. 4 indexed citations
3.
Wenglén, Christina, et al.. (2023). Targeting serotonin receptor 2B inhibits TGFβ induced differentiation of human vascular smooth muscle cells. European Journal of Pharmacology. 944. 175570–175570. 3 indexed citations
4.
Tornling, Göran, et al.. (2020). Pathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases. International Journal of Molecular Sciences. 22(1). 225–225. 17 indexed citations
7.
Rydell‐Törmänen, Kristina, et al.. (2018). Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro – a potential pathway affecting proliferation. Scientific Reports. 8(1). 1927–1927. 13 indexed citations
8.
Wenglén, Christina, et al.. (2018). Effects of 5-Hydroxytryptamine Class 2 Receptor Antagonists on Bronchoconstriction and Pulmonary Remodeling Processes. American Journal Of Pathology. 188(5). 1113–1119. 20 indexed citations
9.
Wenglén, Christina, et al.. (2017). SAT0314 A novel highly selective 5-hydroxytryptamine 2B (5-HT2B) receptor antagonist ameliorating fibrosis in preclinical models of systemic sclerosis. Annals of the Rheumatic Diseases. 76. 891–891. 2 indexed citations
10.
Rydell‐Törmänen, Kristina, et al.. (2016). 5‐HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo. Physiological Reports. 4(15). 27 indexed citations
11.
Lood, Christian, Helena Tydén, Birgitta Gullstrand, et al.. (2015). Type I Interferon-Mediated Skewing of the Serotonin Synthesis Is Associated with Severe Disease in Systemic Lupus Erythematosus. PLoS ONE. 10(4). e0125109–e0125109. 51 indexed citations
12.
Hessle, Lovisa, Gunhild A. Stordalen, Christina Wenglén, et al.. (2013). The Skeletal Phenotype of Chondroadherin Deficient Mice. PLoS ONE. 8(6). e63080–e63080. 34 indexed citations
13.
Haglund, Lisbet, Viveka Tillgren, Laura Addis, et al.. (2010). Identification and Characterization of the Integrin α2β1 Binding Motif in Chondroadherin Mediating Cell Attachment. Journal of Biological Chemistry. 286(5). 3925–3934. 28 indexed citations
14.
Addis, Laura, et al.. (2008). Purification, crystallization and preliminary X-ray diffraction analysis of human chondroadherin. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 64(6). 516–519. 1 indexed citations
15.
Schedel, J, Christina Wenglén, Oliver Distler, et al.. (2004). Differential Adherence of Osteoarthritis and Rheumatoid Arthritis Synovial Fibroblasts to Cartilage and Bone Matrix Proteins and its Implication for Osteoarthritis Pathogenesis. Scandinavian Journal of Immunology. 60(5). 514–523. 24 indexed citations
16.
Wiberg, Charlotte, Dick Heinegård, Christina Wenglén, Rupert Timpl, & Matthias Mörgelin. (2002). Biglycan Organizes Collagen VI into Hexagonal-like Networks Resembling Tissue Structures. Journal of Biological Chemistry. 277(51). 49120–49126. 140 indexed citations
17.
Månsson, Bengt, Christina Wenglén, Matthias Mörgelin, Tore Saxne, & Dick Heinegård. (2001). Association of Chondroadherin with Collagen Type II. Journal of Biological Chemistry. 276(35). 32883–32888. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026